vs
Digimarc CORP（DMRC）与Taysha Gene Therapies, Inc.（TSHA）财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是Taysha Gene Therapies, Inc.的1.6倍（$8.9M vs $5.5M），Digimarc CORP净利率更高（-47.2% vs -507.8%，领先460.5%），Taysha Gene Therapies, Inc.同比增速更快（171.3% vs 2.9%），过去两年Taysha Gene Therapies, Inc.的营收复合增速更高（26.8% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Taysha基因疗法公司是一家处于临床阶段的生物技术企业，专注开发基于腺相关病毒（AAV）的基因疗法，用于治疗存在大量未满足医疗需求的罕见单基因型中枢神经系统疾病，管线覆盖多种致命性神经病症，核心市场面向北美及欧洲地区。
DMRC vs TSHA — 直观对比
营收规模更大
DMRC
是对方的1.6倍
$5.5M
营收增速更快
TSHA
高出168.4%
2.9%
净利率更高
DMRC
高出460.5%
-507.8%
两年增速更快
TSHA
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $5.5M |
| 净利润 | $-4.2M | $-27.9M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -516.0% |
| 净利率 | -47.2% | -507.8% |
| 营收同比 | 2.9% | 171.3% |
| 净利润同比 | 51.4% | -48.3% |
| 每股收益（稀释后） | $-0.18 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCTSHA
| Q4 25 | $8.9M | $5.5M | ||
| Q3 25 | $7.6M | $0 | ||
| Q2 25 | $8.0M | $2.0M | ||
| Q1 25 | $9.4M | $2.3M | ||
| Q4 24 | $8.7M | $2.0M | ||
| Q3 24 | $9.4M | $1.8M | ||
| Q2 24 | $10.4M | $1.1M | ||
| Q1 24 | $9.9M | $3.4M |
净利润DMRCTSHA
| Q4 25 | $-4.2M | $-27.9M | ||
| Q3 25 | $-8.2M | $-32.7M | ||
| Q2 25 | $-8.2M | $-26.9M | ||
| Q1 25 | $-11.7M | $-21.5M | ||
| Q4 24 | $-8.6M | $-18.8M | ||
| Q3 24 | $-10.8M | $-25.5M | ||
| Q2 24 | $-9.3M | $-20.9M | ||
| Q1 24 | $-10.3M | $-24.1M |
毛利率DMRCTSHA
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCTSHA
| Q4 25 | -48.2% | -516.0% | ||
| Q3 25 | -109.7% | — | ||
| Q2 25 | -105.2% | -1347.1% | ||
| Q1 25 | -128.9% | -930.5% | ||
| Q4 24 | -105.1% | -985.8% | ||
| Q3 24 | -120.4% | -1448.4% | ||
| Q2 24 | -96.2% | -1915.4% | ||
| Q1 24 | -109.2% | -713.3% |
净利率DMRCTSHA
| Q4 25 | -47.2% | -507.8% | ||
| Q3 25 | -106.9% | — | ||
| Q2 25 | -102.6% | -1353.6% | ||
| Q1 25 | -125.2% | -935.2% | ||
| Q4 24 | -99.9% | -929.0% | ||
| Q3 24 | -113.9% | -1427.5% | ||
| Q2 24 | -89.3% | -1882.0% | ||
| Q1 24 | -104.0% | -705.4% |
每股收益（稀释后）DMRCTSHA
| Q4 25 | $-0.18 | $-0.08 | ||
| Q3 25 | $-0.38 | $-0.09 | ||
| Q2 25 | $-0.38 | $-0.09 | ||
| Q1 25 | $-0.55 | $-0.08 | ||
| Q4 24 | $-0.40 | $-0.07 | ||
| Q3 24 | $-0.50 | $-0.10 | ||
| Q2 24 | $-0.43 | $-0.09 | ||
| Q1 24 | $-0.50 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $319.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $246.9M |
| 总资产 | $53.0M | $343.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCTSHA
| Q4 25 | $12.9M | $319.8M | ||
| Q3 25 | $12.6M | $297.3M | ||
| Q2 25 | $16.1M | $312.8M | ||
| Q1 25 | $21.6M | $116.6M | ||
| Q4 24 | $28.7M | $139.0M | ||
| Q3 24 | $33.7M | $157.7M | ||
| Q2 24 | $41.5M | $172.7M | ||
| Q1 24 | $48.9M | $124.0M |
股东权益DMRCTSHA
| Q4 25 | $40.2M | $246.9M | ||
| Q3 25 | $41.4M | $219.0M | ||
| Q2 25 | $46.5M | $248.7M | ||
| Q1 25 | $50.0M | $55.1M | ||
| Q4 24 | $61.4M | $71.5M | ||
| Q3 24 | $70.2M | $88.8M | ||
| Q2 24 | $77.2M | $108.9M | ||
| Q1 24 | $84.5M | $53.8M |
总资产DMRCTSHA
| Q4 25 | $53.0M | $343.3M | ||
| Q3 25 | $55.4M | $316.6M | ||
| Q2 25 | $60.7M | $333.3M | ||
| Q1 25 | $66.5M | $138.4M | ||
| Q4 24 | $75.8M | $160.4M | ||
| Q3 24 | $85.0M | $180.2M | ||
| Q2 24 | $93.4M | $200.4M | ||
| Q1 24 | $99.7M | $153.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-26.7M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCTSHA
| Q4 25 | $991.0K | $-26.7M | ||
| Q3 25 | $-2.6M | $-24.2M | ||
| Q2 25 | $-4.7M | $-20.2M | ||
| Q1 25 | $-5.5M | $-22.0M | ||
| Q4 24 | $-4.2M | $-18.3M | ||
| Q3 24 | $-7.1M | $-21.6M | ||
| Q2 24 | $-6.8M | $-21.5M | ||
| Q1 24 | $-8.4M | $-19.8M |
自由现金流DMRCTSHA
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | $-24.3M | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | $-18.3M | ||
| Q3 24 | $-7.2M | $-21.6M | ||
| Q2 24 | $-6.9M | $-21.7M | ||
| Q1 24 | $-8.5M | $-19.9M |
自由现金流率DMRCTSHA
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -49.1% | -905.5% | ||
| Q3 24 | -75.7% | -1210.9% | ||
| Q2 24 | -66.1% | -1951.9% | ||
| Q1 24 | -85.8% | -584.5% |
资本支出强度DMRCTSHA
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.7% | 2.0% | ||
| Q2 24 | 0.3% | 18.1% | ||
| Q1 24 | 1.1% | 4.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
TSHA
暂无分部数据
